NCT01735955 2024-02-08Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored StudyNovartisPhase 4 Completed57 enrolled 8 charts
NCT00237185 2014-08-19A Study of the Efficacy and Safety of Imatinib Mesylate in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing C-kit GeneNovartisPhase 2 Completed148 enrolled 17 charts